Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.51
+0.22 (2.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Upstream Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 518 | 1,467 | 881 | - | - |
| Market Cap Growth | 30.91% | 66.51% | - | - | - |
| Enterprise Value | 177 | 1,096 | 1,043 | - | - |
| Last Close Price | 9.51 | 27.15 | 16.44 | - | - |
| PS Ratio | 181.34 | 514.07 | 371.78 | - | - |
| PB Ratio | 1.52 | 4.32 | 1.88 | - | - |
| P/TBV Ratio | 1.52 | 4.32 | 1.88 | - | - |
| EV/Sales Ratio | 62.12 | 384.07 | 440.20 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0 | 0.01 |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.00 | -1.02 | -2.54 |
| Net Debt / EBITDA Ratio | 2.12 | 2.12 | 6.03 | 2.74 | 0.71 |
| Net Debt / FCF Ratio | 2.55 | 2.55 | 7.85 | 2.88 | 0.89 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.04 | - |
| Quick Ratio | 25.56 | 25.56 | 43.93 | 16.89 | 3.60 |
| Current Ratio | 26.15 | 26.15 | 44.63 | 17.96 | 3.77 |
| Return on Equity (ROE) | -35.43% | -35.43% | -21.75% | -35.88% | - |
| Return on Assets (ROA) | -23.99% | -23.99% | -16.23% | -36.96% | - |
| Return on Capital Employed (ROCE) | -47.10% | -47.10% | -16.50% | -36.20% | -175.50% |
| Earnings Yield | -27.72% | -9.78% | -7.13% | - | - |
| FCF Yield | -25.78% | -9.10% | -6.77% | - | - |
| Buyback Yield / Dilution | -293.59% | -293.59% | -363.22% | -5.49% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.